- Home
- CMMB vs INHD Comparison
CMMB vs INHD Comparison
Compare CMMB & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- INHD
- Stock Information
- Founded
- CMMB 2004
- INHD 2019
- Country
- CMMB Israel
- INHD United States
- Employees
- CMMB N/A
- INHD N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- INHD
- Sector
- CMMB Health Care
- INHD
- Exchange
- CMMB Nasdaq
- INHD Nasdaq
- Market Cap
- CMMB 23.0M
- INHD 19.8M
- IPO Year
- CMMB N/A
- INHD 2023
- Fundamental
- Price
- CMMB $1.32
- INHD $1.25
- Analyst Decision
- CMMB Strong Buy
- INHD
- Analyst Count
- CMMB 2
- INHD 0
- Target Price
- CMMB $8.50
- INHD N/A
- AVG Volume (30 Days)
- CMMB 109.4K
- INHD 2.7M
- Earning Date
- CMMB 05-15-2025
- INHD 05-02-2025
- Dividend Yield
- CMMB N/A
- INHD N/A
- EPS Growth
- CMMB N/A
- INHD N/A
- EPS
- CMMB N/A
- INHD N/A
- Revenue
- CMMB N/A
- INHD $1,559,595.00
- Revenue This Year
- CMMB N/A
- INHD N/A
- Revenue Next Year
- CMMB N/A
- INHD N/A
- P/E Ratio
- CMMB N/A
- INHD N/A
- Revenue Growth
- CMMB N/A
- INHD 287.83
- 52 Week Low
- CMMB $0.78
- INHD $1.11
- 52 Week High
- CMMB $2.55
- INHD $19.78
- Technical
- Relative Strength Index (RSI)
- CMMB 50.69
- INHD 29.64
- Support Level
- CMMB $1.31
- INHD $1.16
- Resistance Level
- CMMB $1.44
- INHD $1.57
- Average True Range (ATR)
- CMMB 0.08
- INHD 1.61
- MACD
- CMMB 0.00
- INHD -0.10
- Stochastic Oscillator
- CMMB 54.55
- INHD 0.75
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.